Breakthrough COVID19 infections after vaccinations in healthcare and other workers in a chronic care medical facility in New Delhi, India

Vaccinations for COVID19 are now open to all adults in India. However, spread of COVID19 infection continues unabated. We aimed to ascertain number of breakthrough COVID19 infections after vaccinations in a chronic care, diabetes-centric healthcare facility. We reviewed rigorously maintained data of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes & metabolic syndrome clinical research & reviews 2021-05, Vol.15 (3), p.1007-1008
Hauptverfasser: Tyagi, Kanika, Ghosh, Amerta, Nair, Dipti, Dutta, Koel, Singh Bhandari, Prakash, Ahmed Ansari, Irshad, Misra, Anoop
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1008
container_issue 3
container_start_page 1007
container_title Diabetes & metabolic syndrome clinical research & reviews
container_volume 15
creator Tyagi, Kanika
Ghosh, Amerta
Nair, Dipti
Dutta, Koel
Singh Bhandari, Prakash
Ahmed Ansari, Irshad
Misra, Anoop
description Vaccinations for COVID19 are now open to all adults in India. However, spread of COVID19 infection continues unabated. We aimed to ascertain number of breakthrough COVID19 infections after vaccinations in a chronic care, diabetes-centric healthcare facility. We reviewed rigorously maintained data of vaccinations, health status, symptoms of COVID19 & RT-PCR testing of all staff (doctors, nurses, paramedical workers, and other staff) in our health care facility from January 16, 2021 till date. Out of 123 employees, 113 were vaccinated (Covaxin, 28, Covishield, 85). Second dose was completed in 107 (94.7%) and first dose in 6 persons (5.3%). Symptomatic COVD19 infections occurred in 19 persons (16.9%) post any dose of vaccine. Symptomatic breakthrough infections > 14 days after second dose occurred in 15 persons (13.3%). Except one (required hospitalization), all 14 had mild COVID19 disease. We report mild symptomatic breakthrough infections as seen in our health care facility. Research in breakthrough infections in India should be extended to other institutions and community to obtain larger data. •Data regarding breakthrough infections after vaccination is needed in India.•In our chronic care medical facility, symptomatic breakthrough infections occurred in 15/113 (13.3%) of fully vaccinated persons.•Except one, all persons with breakthrough infections had mild COVID19.
doi_str_mv 10.1016/j.dsx.2021.05.001
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8091733</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1871402121001399</els_id><sourcerecordid>2528185748</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3661-a72efb2a1e4c893cfd81423d93dade33f90a0cf1e59f619063ef104403934b7c3</originalsourceid><addsrcrecordid>eNp9kc9uEzEQh1eIipbCA3BBPnJgt571_rOQkCAtEKmiF-BqTbzjrtONXexNSh-hb42TtFW5cLLl-ebn0XxZ9gZ4ARyak2XRxz9FyUsoeF1wDs-yI-jaLudCVM93d8irVD7MXsa45LyuZSlfZIdCSAkdr4-yu8-B8Goagl9fDmx28Wt-CpJZZ0hP1rvI0EwU2Aa1tg73T9axgXCcBo2BGLqe-WlI0I0PVxR2dWQ6RTqr2Y5ZUW81jsygtqOdbrfId7phpzQO9j2bu97iq-zA4Bjp9f15nP38cvZj9i0_v_g6n306z7VoGsixLcksSgSqdCeFNn0HVSl6KXrsSQgjOXJtgGppGpC8EWSAVxUXUlSLVovj7OM-93q9SHNpclPAUV0Hu8Jwqzxa9W_F2UFd-o3quIRWiBTw7j4g-N9ripNa2ahpHNGRX0dV1mUHXd1WXUJhj-rgYwxkHr8BrrYK1VIlhWqrUPFaJYWp5-3T-R47Hpwl4MMeoLSljaWgorbkdNpxSNZU7-1_4v8CMGOulw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2528185748</pqid></control><display><type>article</type><title>Breakthrough COVID19 infections after vaccinations in healthcare and other workers in a chronic care medical facility in New Delhi, India</title><source>Access via ScienceDirect (Elsevier)</source><creator>Tyagi, Kanika ; Ghosh, Amerta ; Nair, Dipti ; Dutta, Koel ; Singh Bhandari, Prakash ; Ahmed Ansari, Irshad ; Misra, Anoop</creator><creatorcontrib>Tyagi, Kanika ; Ghosh, Amerta ; Nair, Dipti ; Dutta, Koel ; Singh Bhandari, Prakash ; Ahmed Ansari, Irshad ; Misra, Anoop</creatorcontrib><description>Vaccinations for COVID19 are now open to all adults in India. However, spread of COVID19 infection continues unabated. We aimed to ascertain number of breakthrough COVID19 infections after vaccinations in a chronic care, diabetes-centric healthcare facility. We reviewed rigorously maintained data of vaccinations, health status, symptoms of COVID19 &amp; RT-PCR testing of all staff (doctors, nurses, paramedical workers, and other staff) in our health care facility from January 16, 2021 till date. Out of 123 employees, 113 were vaccinated (Covaxin, 28, Covishield, 85). Second dose was completed in 107 (94.7%) and first dose in 6 persons (5.3%). Symptomatic COVD19 infections occurred in 19 persons (16.9%) post any dose of vaccine. Symptomatic breakthrough infections &gt; 14 days after second dose occurred in 15 persons (13.3%). Except one (required hospitalization), all 14 had mild COVID19 disease. We report mild symptomatic breakthrough infections as seen in our health care facility. Research in breakthrough infections in India should be extended to other institutions and community to obtain larger data. •Data regarding breakthrough infections after vaccination is needed in India.•In our chronic care medical facility, symptomatic breakthrough infections occurred in 15/113 (13.3%) of fully vaccinated persons.•Except one, all persons with breakthrough infections had mild COVID19.</description><identifier>ISSN: 1871-4021</identifier><identifier>EISSN: 1878-0334</identifier><identifier>DOI: 10.1016/j.dsx.2021.05.001</identifier><identifier>PMID: 33991805</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><ispartof>Diabetes &amp; metabolic syndrome clinical research &amp; reviews, 2021-05, Vol.15 (3), p.1007-1008</ispartof><rights>2021 Diabetes India</rights><rights>Copyright © 2021 Diabetes India. Published by Elsevier Ltd. All rights reserved.</rights><rights>2021 Diabetes India. Published by Elsevier Ltd. All rights reserved. 2021 Diabetes India</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3661-a72efb2a1e4c893cfd81423d93dade33f90a0cf1e59f619063ef104403934b7c3</citedby><cites>FETCH-LOGICAL-c3661-a72efb2a1e4c893cfd81423d93dade33f90a0cf1e59f619063ef104403934b7c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.dsx.2021.05.001$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33991805$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tyagi, Kanika</creatorcontrib><creatorcontrib>Ghosh, Amerta</creatorcontrib><creatorcontrib>Nair, Dipti</creatorcontrib><creatorcontrib>Dutta, Koel</creatorcontrib><creatorcontrib>Singh Bhandari, Prakash</creatorcontrib><creatorcontrib>Ahmed Ansari, Irshad</creatorcontrib><creatorcontrib>Misra, Anoop</creatorcontrib><title>Breakthrough COVID19 infections after vaccinations in healthcare and other workers in a chronic care medical facility in New Delhi, India</title><title>Diabetes &amp; metabolic syndrome clinical research &amp; reviews</title><addtitle>Diabetes Metab Syndr</addtitle><description>Vaccinations for COVID19 are now open to all adults in India. However, spread of COVID19 infection continues unabated. We aimed to ascertain number of breakthrough COVID19 infections after vaccinations in a chronic care, diabetes-centric healthcare facility. We reviewed rigorously maintained data of vaccinations, health status, symptoms of COVID19 &amp; RT-PCR testing of all staff (doctors, nurses, paramedical workers, and other staff) in our health care facility from January 16, 2021 till date. Out of 123 employees, 113 were vaccinated (Covaxin, 28, Covishield, 85). Second dose was completed in 107 (94.7%) and first dose in 6 persons (5.3%). Symptomatic COVD19 infections occurred in 19 persons (16.9%) post any dose of vaccine. Symptomatic breakthrough infections &gt; 14 days after second dose occurred in 15 persons (13.3%). Except one (required hospitalization), all 14 had mild COVID19 disease. We report mild symptomatic breakthrough infections as seen in our health care facility. Research in breakthrough infections in India should be extended to other institutions and community to obtain larger data. •Data regarding breakthrough infections after vaccination is needed in India.•In our chronic care medical facility, symptomatic breakthrough infections occurred in 15/113 (13.3%) of fully vaccinated persons.•Except one, all persons with breakthrough infections had mild COVID19.</description><issn>1871-4021</issn><issn>1878-0334</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kc9uEzEQh1eIipbCA3BBPnJgt571_rOQkCAtEKmiF-BqTbzjrtONXexNSh-hb42TtFW5cLLl-ebn0XxZ9gZ4ARyak2XRxz9FyUsoeF1wDs-yI-jaLudCVM93d8irVD7MXsa45LyuZSlfZIdCSAkdr4-yu8-B8Goagl9fDmx28Wt-CpJZZ0hP1rvI0EwU2Aa1tg73T9axgXCcBo2BGLqe-WlI0I0PVxR2dWQ6RTqr2Y5ZUW81jsygtqOdbrfId7phpzQO9j2bu97iq-zA4Bjp9f15nP38cvZj9i0_v_g6n306z7VoGsixLcksSgSqdCeFNn0HVSl6KXrsSQgjOXJtgGppGpC8EWSAVxUXUlSLVovj7OM-93q9SHNpclPAUV0Hu8Jwqzxa9W_F2UFd-o3quIRWiBTw7j4g-N9ripNa2ahpHNGRX0dV1mUHXd1WXUJhj-rgYwxkHr8BrrYK1VIlhWqrUPFaJYWp5-3T-R47Hpwl4MMeoLSljaWgorbkdNpxSNZU7-1_4v8CMGOulw</recordid><startdate>20210501</startdate><enddate>20210501</enddate><creator>Tyagi, Kanika</creator><creator>Ghosh, Amerta</creator><creator>Nair, Dipti</creator><creator>Dutta, Koel</creator><creator>Singh Bhandari, Prakash</creator><creator>Ahmed Ansari, Irshad</creator><creator>Misra, Anoop</creator><general>Elsevier Ltd</general><general>Diabetes India. Published by Elsevier Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20210501</creationdate><title>Breakthrough COVID19 infections after vaccinations in healthcare and other workers in a chronic care medical facility in New Delhi, India</title><author>Tyagi, Kanika ; Ghosh, Amerta ; Nair, Dipti ; Dutta, Koel ; Singh Bhandari, Prakash ; Ahmed Ansari, Irshad ; Misra, Anoop</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3661-a72efb2a1e4c893cfd81423d93dade33f90a0cf1e59f619063ef104403934b7c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tyagi, Kanika</creatorcontrib><creatorcontrib>Ghosh, Amerta</creatorcontrib><creatorcontrib>Nair, Dipti</creatorcontrib><creatorcontrib>Dutta, Koel</creatorcontrib><creatorcontrib>Singh Bhandari, Prakash</creatorcontrib><creatorcontrib>Ahmed Ansari, Irshad</creatorcontrib><creatorcontrib>Misra, Anoop</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Diabetes &amp; metabolic syndrome clinical research &amp; reviews</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tyagi, Kanika</au><au>Ghosh, Amerta</au><au>Nair, Dipti</au><au>Dutta, Koel</au><au>Singh Bhandari, Prakash</au><au>Ahmed Ansari, Irshad</au><au>Misra, Anoop</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Breakthrough COVID19 infections after vaccinations in healthcare and other workers in a chronic care medical facility in New Delhi, India</atitle><jtitle>Diabetes &amp; metabolic syndrome clinical research &amp; reviews</jtitle><addtitle>Diabetes Metab Syndr</addtitle><date>2021-05-01</date><risdate>2021</risdate><volume>15</volume><issue>3</issue><spage>1007</spage><epage>1008</epage><pages>1007-1008</pages><issn>1871-4021</issn><eissn>1878-0334</eissn><abstract>Vaccinations for COVID19 are now open to all adults in India. However, spread of COVID19 infection continues unabated. We aimed to ascertain number of breakthrough COVID19 infections after vaccinations in a chronic care, diabetes-centric healthcare facility. We reviewed rigorously maintained data of vaccinations, health status, symptoms of COVID19 &amp; RT-PCR testing of all staff (doctors, nurses, paramedical workers, and other staff) in our health care facility from January 16, 2021 till date. Out of 123 employees, 113 were vaccinated (Covaxin, 28, Covishield, 85). Second dose was completed in 107 (94.7%) and first dose in 6 persons (5.3%). Symptomatic COVD19 infections occurred in 19 persons (16.9%) post any dose of vaccine. Symptomatic breakthrough infections &gt; 14 days after second dose occurred in 15 persons (13.3%). Except one (required hospitalization), all 14 had mild COVID19 disease. We report mild symptomatic breakthrough infections as seen in our health care facility. Research in breakthrough infections in India should be extended to other institutions and community to obtain larger data. •Data regarding breakthrough infections after vaccination is needed in India.•In our chronic care medical facility, symptomatic breakthrough infections occurred in 15/113 (13.3%) of fully vaccinated persons.•Except one, all persons with breakthrough infections had mild COVID19.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>33991805</pmid><doi>10.1016/j.dsx.2021.05.001</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1871-4021
ispartof Diabetes & metabolic syndrome clinical research & reviews, 2021-05, Vol.15 (3), p.1007-1008
issn 1871-4021
1878-0334
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8091733
source Access via ScienceDirect (Elsevier)
title Breakthrough COVID19 infections after vaccinations in healthcare and other workers in a chronic care medical facility in New Delhi, India
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T18%3A43%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Breakthrough%20COVID19%20infections%20after%20vaccinations%20in%20healthcare%20and%20other%20workers%20in%20a%20chronic%20care%20medical%20facility%20in%20New%20Delhi,%20India&rft.jtitle=Diabetes%20&%20metabolic%20syndrome%20clinical%20research%20&%20reviews&rft.au=Tyagi,%20Kanika&rft.date=2021-05-01&rft.volume=15&rft.issue=3&rft.spage=1007&rft.epage=1008&rft.pages=1007-1008&rft.issn=1871-4021&rft.eissn=1878-0334&rft_id=info:doi/10.1016/j.dsx.2021.05.001&rft_dat=%3Cproquest_pubme%3E2528185748%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2528185748&rft_id=info:pmid/33991805&rft_els_id=S1871402121001399&rfr_iscdi=true